PHVS vs VRTX: Which Stock is Better?
Side-by-side comparison of Pharvaris Nv and Vertex Pharmaceuticals Inc in 2026
PHVS
Pharvaris Nv
$28.58
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | PHVS | VRTX | Winner |
|---|---|---|---|
| Market Cap | $1.88B | $110.81B | VRTX |
| P/E Ratio | N/A | 28.42 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 0.0% | 53.7% | VRTX |
Analyze PHVS
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHVS or VRTX a better investment?
Comparing PHVS and VRTX: Pharvaris Nv has a market cap of $1.88B while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHVS and VRTX?
PHVS (Pharvaris Nv) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHVS or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHVS or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for PHVS.
Which company is more profitable: PHVS or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for PHVS.
Which is the larger company: PHVS or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $1.88B for PHVS.
Should I buy PHVS or VRTX in 2026?
Both PHVS and VRTX have investment merit. PHVS trades at $28.58 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHVS and VRTX stock?
Key differences: Market Cap ($1.88B vs $110.81B), P/E Ratio (N/A vs 28.4x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).